Phibro Animal Health Corporation (PAHC)

Currency in USD
38.32
-0.69(-1.77%)
Closed·
39.00+0.68(+1.77%)
·
PAHC Scorecard
Full Analysis
Net income is expected to grow this year
PAHC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
38.0939.86
52 wk Range
16.1641.57
Key Statistics
Prev. Close
39.01
Open
39.13
Day's Range
38.09-39.86
52 wk Range
16.16-41.57
Volume
308.9K
Average Volume (3m)
330.05K
1-Year Change
81.35%
Book Value / Share
7.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PAHC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
35.75
Downside
-6.71%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal’s health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock’s diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Employees
2475

Phibro Animal Health Corporation Earnings Call Summary for Q4/2025

  • Q4 EPS of $0.57 beat forecast by 9.62%; revenue reached $378.7M, up 39% YoY; stock surged 9.63% post-earnings
  • Animal Health segment grew 53% in Q4; company expanding geographic presence and entering new markets like U.S. beef cattle
  • FY2026 guidance: net sales $1.425B-$1.475B (10-14% growth); Adjusted EBITDA $225M-$235M; Adjusted net income $103M-$110M
  • Fibro Forward program to drive growth; CEO projects strong sales; CFO expects program to peak in FY2027
  • Risks include tariffs, mature MFA market, global economic uncertainties, and integration challenges with Zoetis MFA portfolio
Last Updated: 28/08/2025, 14:50
Read Full Transcript

Compare PAHC to Peers and Sector

Metrics to compare
PAHC
Peers
Sector
Relationship
P/E Ratio
32.2x6.4x−0.7x
PEG Ratio
0.020.160.00
Price/Book
5.4x1.8x2.6x
Price / LTM Sales
1.2x1.6x3.4x
Upside (Analyst Target)
−9.5%18.1%35.5%
Fair Value Upside
Unlock11.6%3.3%Unlock

Analyst Ratings

1 Buy
2 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 35.75
(-6.71% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.19%
Dividend Yield
1.25%
Industry Median 2.80%
Annualised payout
0.48
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 27, 2025
EPS / Forecast
0.57 / 0.52
Revenue / Forecast
378.70M / 362.24M
EPS Revisions
Last 90 days

PAHC Income Statement

People Also Watch

27.28
HRMY
+1.94%
28.540
RIGL
+1.49%
200.74
ALAB
-4.23%
50.460
IREN
+7.32%
286.14
ORCL
-0.91%

FAQ

What Stock Exchange Does Phibro Trade On?

Phibro is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Phibro?

The stock symbol for Phibro is "PAHC."

What Is the Phibro Market Cap?

As of today, Phibro market cap is 1.55B.

What Is Phibro's Earnings Per Share (TTM)?

The Phibro EPS (TTM) is 1.19.

When Is the Next Phibro Earnings Date?

Phibro will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is PAHC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Phibro Stock Split?

Phibro has split 0 times.

How Many Employees Does Phibro Have?

Phibro has 2475 employees.

What is the current trading status of Phibro (PAHC)?

As of 04 Oct 2025, Phibro (PAHC) is trading at a price of 38.32, with a previous close of 39.01. The stock has fluctuated within a day range of 38.09 to 39.86, while its 52-week range spans from 16.16 to 41.57.

What Is Phibro (PAHC) Price Target According to Analysts?

The average 12-month price target for Phibro is USD35.75, with a high estimate of USD45 and a low estimate of USD27. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -6.71% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.